Vaddi Krishna's Form 4 filing
Prelude Therapeutics Inc (PRLD) · filed Mar 18, 2025
- Accession no.
- 0001562180-25-002541
- Filed
- Mar 18, 2025
- Trade date
- Mar 14-17, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $29.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vaddi KrishnaCIK 0001824633 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Common Stock | PPurchaseAcquired | +29,999 | $0.75 | +$22,499.25 | 1,294,774 | Direct | |
| Mar 17, 2025 | Common Stock | PPurchaseAcquired | +9,106 | $0.75 | +$6,829.5 | 1,303,880 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.